Radiographic changes of the mandible after proton beam radiotherapy for oral cancer: A case report

Introduction: Radiation-induced osteomyelitis or osteoradionecrosis of the jaw bone is one of the most severe adverse effects of radiotherapy sometimes experienced by head and neck cancer patients. We report on the observed radiographic changes after proton radiotherapy for a patient with squamous cell carcinoma in the mandibular bone. Case Report: We report on a case of a deeply infiltrating squamous cell carcinoma in the mandible and treated with the proton beam radiotherapy. We describe the radiographic changes of the mandible after proton beam therapy. Primary lesion disappeared and the obvious resorption of the left mandible was observed. However, the images after proton beam therapy showed continued new bone formation and regeneration of the cortical bone of the mandible. Conclusion: This case illustrates the new bone formation and regeneration of the cortical bone of the mandible after the proton beam radiotherapy. Careful observations in more cases need to verify whether the effect of the proton beam radiotherapy maintaining a given dose while decreasing unnecessary dose to surrounding normal tissue is demonstrated or not. (This page in not part of the published article.) International Journal of Case Reports and Images, Vol. 8 No. 12, December 2017. ISSN: 0976-3198 Int J Case Rep Images 2017;8(12):787–791. www.ijcasereportsandimages.com Konishi et al. 787 CASE REPORT PEER REVIEWED | OPEN ACCESS Radiographic changes of the mandible after proton beam radiotherapy for oral cancer: A case report Masaru Konishi, Yoshikazu Suei, Minoru Fujita, Keiji Tanimoto


INTRODUCTION
One of the adverse effects of radiotherapy for head and neck cancer is radiation-induced osteomyelitis or osteoradionecrosis (ORN) of the jaw bone. A lot of clinical and physical factors have been reported to be associated with the risk of ORN. They include patient-, tumor-, and treatment-related variables [1,2]. Tolerance dose of the mandibular bone was reported from 60-72 Gy [3]. Fujita et al. reported that a total dose of 90 Gy or more and a dose rate of 0.55 Gy/h or higher were associated with a significant increase in the incidence of ORN at the brachytherapy for oral tongue cancer [4]. Oral health status is a risk factor for ORN, and oral health care is an important element in the prevention of ORN.
Good oral conditions before and after radiotherapy for all irradiated head and neck cancer patients are very important to prevent ORN [2,5]. The multidisciplinary team communications like the consultation of dentists or dental hygienists before the radiotherapy are commonly recommended. The managements of ORN are reported such as a conservative management, ultrasound therapy, hyperbaric oxygen [6,7]. In any case, once ORN occurred, it often can persist for a long time and be hard to manage.
Owing to the physical characteristics depositing the bulk of the radiation dose in a highly confined area of the proton beam, some lesions became treatable with the proton beam radiotherapy even if it was the treatment-resistant tumors in sensitive location [8]. Numerous studies have reported on ORN resulting from radiotherapy with X-rays. However, few reports exist on ORN resulting from proton beam radiotherapy. We report on the observed radiographic changes after proton radiotherapy for a patient with squamous cell carcinoma in the mandibular bone.

CASE REPORT
A 60-year-old male was referred to the department of oral and maxillofacial surgery with a history of persistent swelling on the left side of his face. He has been presenting with soft swelling of the left cheek and sub-mandibular region for two weeks. He was also experiencing paresthesia of the third division of the trigeminal nerve, and had limited range of motion of the jaw. The lower left second molar had been extracted and the socket was covered with soft granulation tissue. Histopathological diagnosis was based on a biopsy of the gingiva confirmed squamous cell carcinoma.
Panoramic radiography at the initial visit showed a moss-eaten appearance of the left mandible ( Figure  1). Computed tomography (CT) scan revealed a wellenhanced mass and bone destruction of the left mandible ( Figure 2). Initially, a surgical approach for treatment was considered. However, after 18F-fluorodeoxyglucose positron emission tomography of the region, the case was deemed inoperable as tumor invasion into the cranial   fossa and was suspected along the trigeminal nerve. The patient was thus treated with chemotherapy (cisplatin and 5-fluorouracil) and proton beam therapy to 70 Gy in 35 fractions.
A panoramic image one month after proton beam therapy is shown in Figure 3. At that time, there was obvious resorption and deformity in the left mandible. The images of cone-beam computed tomography (CBCT) one month after proton radiotherapy ( Figure 4) showed a possible trabecular bony formation at the location of the primary lesion. The cortical bone once adjacent to the lesion was nearly destroyed.
A panoramic image at 10th month post-proton beam therapy ( Figure 5) showed a defect where the left mandible (and tumor) had originally existed and the first molar presented as a floating tooth. Computed tomography scan images at 10th month after proton beam therapy ( Figure 6) showed continued new bone formation and regeneration of the cortical bone of the mandible. The patient experienced extreme occlusal dysfunction as a result of the bone resorption, which was exacerbated at meal times. The patient had a local recurrence one year after proton beam therapy and perished about 19 months after proton beam therapy and 26 months after the first visit.

DISCUSSION
Proton beam therapy is one of the most technologically advanced forms of radiotherapy. Protons differ from traditional megavoltage X-ray radiotherapy owing to the characteristic Bragg peak of a proton beam. The Bragg peak can be described as the deposition of energy at a specific depth in the body as the protons decelerate. The Bragg peak can be placed at any depth in the body   (corresponding to a tumor location), depending on the energy of the beam selected. Conventional radiation therapy faces challenges from side effects because of a relatively high entrance dose as well as a non-zero exit dose. By contrast, proton therapy has a substantially lower entrance dose and no exit dose that reduces damage to healthy tissue surrounding a tumor [9]. In addition to differences in dose deposition; protons have different radiobiological properties compared with photons. Specifically, the relative biological effectiveness (RBE) of protons beam is considered to be 1.1, compared with 1.0 for photons. The head and neck squamous cell carcinoma observed in this case was well suited for proton therapy owing to the improved dose deposition and RBE.
The radiographic features of ORN have many similarities to those of chronic osteomyelitis [10]. An early characteristic change due to therapeutic doses of radiation is a well-defined area of bone resorption within the outer cortical plate of the mandible. Late changes are quite variable and may be predominantly osteolytic or osteosclerotic, or a mixture. Typically, the periphery of a lesion is ill-defined, and the cortical bone of the jaws shows irregular resorption. New periosteal bone formation is uncommon. For comparison, the radiographic findings of the present case and relevant published data resulting from X-ray radiotherapy are given in Table 1 [11]. Published data from patients treated www.ijcasereportsandimages.com

Konishi et al. 790
with X-ray radiotherapy showed sequestrum formation, and the present case also demonstrated an unclear trabecular bone sequestrum formation in the mandible. However, the presentation of this formation in this case was different than what is typically observed with osteoradionecrosis resulting from X-ray radiotherapy. Sequestral formations typically occur in the normal bone areas of the jaw as a result of X-ray radiotherapy. In the present case, the new bone formation started in the mandible where bone resorption had occurred because of the lesion. The amount of new bone formation was very small in the present case and showed a sequestrum formation without bone trabeculae upon CT imaging. With time, it may have been possible to more clearly observe the cancellous and cortical bone on CT images and the trabecular pattern might have been observable with long-term follow-up. However, as the patient passed away 19 months after proton beam therapy, we were not able to observe such radiographic changes. For this reason, we were unable to identify whether the new bone formation observed was a sequestrum. In the present case, the mandible was almost destroyed by the cancerous invasion, but any surviving osteoblasts would have proliferated and led to the bone formation after the proton beam therapy had eliminated the cancer cells.
We compared the radiographic findings of ORN resulting from X-ray radiotherapy with those of ORN from proton beam radiotherapy. One of the main factors in choosing a form of radiotherapy (X-rays or protons) is the physiological state of the disease. Conventional radiotherapy was not indicated for the present case because the lesion had infiltrated deep into the mandibular bone. Osteoradionecrosis resulting from X-ray radiotherapy typically occurs secondary to the treatment of the primary lesion. In the present case, as the primary lesion had extensively infiltrated the mandibular bone, it was assumed that the mandibular bone was concurrently absorbed with the reduction of the lesion resulting from proton beam radiotherapy. Future investigations should consider the radiation-induced changes to bone separately whether or not the primary lesion exists in the bone.

CONCLUSION
Most lesions in the bone do not qualify for curative radiotherapy with X-rays. Typically, radiotherapy is used as a palliative treatment for pain relief or reduction of paralysis risk in patients with bone metastasis. Therefore, it is difficult to predict if the bone absorbed because of the presence of a cancerous lesion will or will not experience new bone formation in the area of the destructed lesion. With the advent of proton beam radiotherapy, the number of diseases which can be curatively treated has increased. As more patients with cancers in the jaw bone are treated with protons, careful observation of any radiation-induced effects such as osteoradionecrosis need to be monitored, classified, and disseminated appropriately. *********

Author Contributions
Masaru Konishi -Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Yoshikazu Suei -Acquisition of data, Drafting the article, Final approval of the version to be published Minoru Fujita -Analysis and interpretation of data, Drafting the article, Final approval of the version to be published Keiji Tanimoto -Analysis and interpretation of data, Drafting the article, Final approval of the version to be published

Guarantor of Submission
The corresponding author is the guarantor of submission.

Edorium Journals: An introduction
Why should you publish with Edorium Journals?
In less than 10 words: "We give you what no one does".

Vision of being the best
We have the vision of making our journals the best and the most authoritative journals in their respective specialties. We are working towards this goal every day.

Exceptional services
We care for you, your work and your time. Our efficient, personalized and courteous services are a testimony to this.

Editorial review
All manuscripts submitted to Edorium Journals undergo pre-processing review followed by multiple rounds of stringent editorial reviews.

Peer review
All manuscripts submitted to Edorium Journals undergo anonymous, double-blind, external peer review.

Early view version
Early View version of your manuscript will be published in the journal within 72 hours of final acceptance.

Manuscript status
From submission to publication of your article you will get regular updates about status of your manuscripts.

Favored author program
One email is all it takes to become our favored author. You will not only get 15% off on all manuscript but also get information and insights about scholarly publishing.

Institutional membership program
Join our Institutional Memberships program and help scholars from your institute make their research accessible to all and save thousands of dollars in publication fees.

Our presence
We have high quality, attractive and easy to read publication format. Our websites are very user friendly and enable you to use the services easily with no hassle.
We request you to have a look at our website to know more about us and our services. Please visit: www.edoriumjournals.com We welcome you to interact with us, share with us, join us and of course publish with us.

Invitation for article submission
We sincerely invite you to submit your valuable research for publication to Edorium Journals.

Six weeks
We give you our commitment that you will get first decision on your manuscript within six weeks (42 days) of submission. If we fail to honor this commitment by even one day, we will give you a 75% Discount Voucher for your next manuscript.

Four weeks
We give you our commitment that after we receive your page proofs, your manuscript will be published in the journal within 14 days (2 weeks). If we fail to honor this commitment by even one day, we will give you a 75% Discount Voucher for your next manuscript.